A carbonic anhydrase inhibitor, Dorzplamide is used for the treatment of glaucoma and ocular hypertension. It is administered as topical opthalmic form and decreases the aqueous humour production.. Reference standards of Dorzolamide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object ( [pname] => N-((4S,6S)-6-Methyl-7,7-dioxido-2-sulfamoyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl)acetamide (BSC) [catalogue_number] => PA BSC 06204803 [category_ids] => ,169, [chemical_name] => [weight] => 338.41 [form] => C10H14N2O5S3 [cas] => 147200-03-1 [pslug] => 147200-03-1-n-4s-6s-6-methyl-7-7-dioxido-2-sulfamoyl-5-6-dihydro-4h-thieno-2-3-b-thiopyran-4-yl-acetamide-bsc-pabsc06204803 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA BSC 06204803
CAS :
Molecular Formula : C10H14N2O5S3
Molecular Weight : 338.41
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
